Concepedia
Statistics
Publications
13
Citations
771
H-Index
12
Active since
1994
Affiliations
AbbVie (United States)(Current)
Pfizer (United States)
Purdue University West Lafayette
Johannes Gutenberg University Mainz
The Ohio State University
Sherry L. Ralston is an author at AbbVie (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
1994–2024
Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451
W. Gregory Roberts, Pamela Whalen, Erik Söderström et al. · Cancer Research · 2005 · 135 citations · Full text
Medicine, Oncology, Pharmacology +17
Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications
Kristin Fabre, Brian R. Berridge, William R. Proctor et al. · Lab on a Chip · 2020 · 106 citations
Pharmacy, Toxicology, Biomems +12
Towards in vitro models for reducing or replacing the use of animals in drug testing
David M. Stresser, Anna K. Kopec, Philip Hewitt et al. · Nature Biomedical Engineering · 2023 · 90 citations
Medicine, Pharmacology, Toxicology +13
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol
Gary D. Stoner, Bruce C. Casto, Sherry L. Ralston et al. · Carcinogenesis · 2002 · 79 citations · Full text
Medicine, Oncology, Pharmacology +14
Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor
Jitesh P. Jani, Richard S. Finn, Mary E. Campbell et al. · Cancer Research · 2007 · 76 citations · Full text
1–5 of 13